Literature DB >> 19159075

Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis.

Mitsunobu Matsushita1, Hiroshi Takakuwa, Naoto Shimeno, Kazushige Uchida, Akiyoshi Nishio, Kazuichi Okazaki.   

Abstract

BACKGROUND: Epinephrine sprayed on the papilla may reduce papillary edema and thus prevent acute pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). The aim of this study was to determine the efficacy of this technique for prevention of post- ERCP pancreatitis.
METHODS: Patients scheduled for ERCP were recruited into this study. We randomized the patients to have 10 ml of either 0.02% epinephrine (epinephrine group) or saline (control group) sprayed on the papilla after diagnostic ERCP and prospectively analyzed the occurrence of post-ERCP pancreatitis between the groups. We recorded duct visualization, presence of pancreatic acinarization, number of injections into the pancreatic duct, total volume of contrast used, and procedure duration.
RESULTS: There was no significant difference between the groups with regard to visualization of the bile duct and/or the main and accessory pancreatic ducts, presence of pancreatic acinarization, number of injections into the pancreatic duct, total volume of contrast used, and procedure duration. Overall, post-ERCP pancreatitis occurred in 4 of the 370 patients (1.1%). The incidence of pancreatitis tended to be higher in the control group (4/185) than in the epinephrine group (0/185) (P = 0.1230).
CONCLUSIONS: Epinephrine sprayed on the papilla tended to prevent post-ERCP pancreatitis, although it was not statistically significant because of the low incidence of pancreatitis. Further studies on the efficacy of this technique in patients at high risk for pancreatitis, and on other volumes and/or concentrations of epinephrine, are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159075     DOI: 10.1007/s00535-008-2272-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  21 in total

1.  Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty.

Authors:  A Ohashi; K Tamada; T Tomiyama; S Wada; T Higashizawa; Y Gotoh; Y Satoh; T Miyata; S Tano; K Ido; K Sugano
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

2.  Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.

Authors:  R T-P Poon; C Yeung; C-L Liu; C-M Lam; W-K Yuen; C-M Lo; A Tang; S-T Fan
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

3.  Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.

Authors:  P Tarnasky; J Cunningham; P Cotton; B Hoffman; Y Palesch; J Freeman; N Curry; R Hawes
Journal:  Endoscopy       Date:  1997-05       Impact factor: 10.093

4.  Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.

Authors:  J Devière; O Le Moine; J L Van Laethem; P Eisendrath; A Ghilain; N Severs; M Cohard
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

5.  Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group.

Authors:  G K Johnson; J E Geenen; J F Johanson; S Sherman; W J Hogan; O Cass
Journal:  Gastrointest Endosc       Date:  1997-09       Impact factor: 9.427

6.  Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.

Authors:  G Cavallini; A Tittobello; L Frulloni; E Masci; A Mariana; V Di Francesco
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

7.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

8.  Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?

Authors:  Thomas Rabenstein; Sylvia Roggenbuck; Baerbel Framke; Peter Martus; Bernhard Fischer; Gerhard Nusko; Steffen Muehldorfer; Juergen Hochberger; Christian Ell; Eckhart G Hahn; H Thomas Schneider
Journal:  Gastrointest Endosc       Date:  2002-04       Impact factor: 9.427

9.  Direct observation of microcirculation of the basal region of rat gastric mucosa.

Authors:  T Ohno; M Katori; K Nishiyama; K Saigenji
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

10.  Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.

Authors:  Manuel Moretó; Manuel Zaballa; Ignacio Casado; Olga Merino; Miguel Rueda; Kléber Ramírez; Raquel Urcelay; Amaia Baranda
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

View more
  9 in total

1.  End of the Road for Epinephrine Spraying of the Papilla to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis?

Authors:  Mark A Gromski; Evan L Fogel
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-06       Impact factor: 11.382

2.  The effect of prophylactic peripapillary administration of methylprednisolone in reducing the risk and severity of postendoscopic retrograde cholangiopancreatography pancreatitis: A double blind clinical trial.

Authors:  Ahmad Shavakhi; Mahsa Khodadustan; Babak Tamizifar
Journal:  J Res Med Sci       Date:  2015-09       Impact factor: 1.852

3.  Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.

Authors:  Kevin E Woods; Field F Willingham
Journal:  World J Gastrointest Endosc       Date:  2010-05-16

4.  Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Ali Akbar Khalesi; Mohammadreza Naghipour; Masood Sepehrimanesh; Kourosh Mojtahedi; Sara Yeganeh; Hamid Saeidi Saedi; Saba Fakhrieh Asl
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-08-31

Review 5.  Prevention of post-ERCP pancreatitis.

Authors:  Jennifer Maranki; Paul Yeaton
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 6.  Prevention of post-ERCP pancreatitis.

Authors:  Lin-Lee Wong; Her-Hsin Tsai
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

7.  Epinephrine in the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Preliminary Study.

Authors:  Behzad Hatami; Seyed Mohammad Hossein Kashfi; Mohammad Abbasinazari; Ehsan Nazemalhosseini Mojarad; Mohammad Amin Pourhoseingholi; Mohammad Reza Zali; Amir Houshang Mohammad Alizadeh
Journal:  Case Rep Gastroenterol       Date:  2018-04-13

8.  Can topical epinephrine application to the papilla prevent pancreatitis after endoscopic retrograde cholangiopancreatography? Results from a double blind, multicentre, placebo controlled, randomised clinical trial.

Authors:  Adriana Fabiola Romano-Munive; J Jesus García-Correa; Luis F García-Contreras; José Ramírez-García; Luis Uscanga; Varenka J Barbero-Becerra; Carlos Moctezuma-Velázquez; Jorge A Ochoa-Rubí; Julio Toledo-Cuque; Gerardo Vázquez-Anaya; Daniel Keil-Ríos; Guido Grajales-Figueroa; Miguel Ángel Ramírez-Luna; Francisco Valdovinos-Andraca; Luis Eduardo Zamora-Nava; Felix Tellez-Avila
Journal:  BMJ Open Gastroenterol       Date:  2021-02

9.  Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Koichi Fujita; Shujiro Yazumi; Hisakazu Matsumoto; Masanori Asada; Hiroko Nebiki; Kazuya Matsumoto; Toru Maruo; Mamoru Takenaka; Takeshi Tomoda; Takumi Onoyama; Akira Kurita; Toshiharu Ueki; Toshiro Katayama; Takashi Kawamura; Hirofumi Kawamoto
Journal:  Dig Endosc       Date:  2022-02-04       Impact factor: 6.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.